FLT3 and acute myeloid leukemia: Thus, as proven by impaired engraftment of two different FLT3-ITD mutated PDX samples in NSG mice, the combination of AZA and creno abrogates stromal protection and effectively diminishes residual LIC in FLT3-ITD AML irrespective of cooperating genetic mutations.